Gesprek : PDP-organisaties over het Product Development Partnership Fonds
De vergadering is geweest
5 november 2014
14:00 - 15:15 uur
14:00 - 15:15 uur
Locatie:
Wttewaall van Stoetwegenzaal
Commissie: algemene commissie voor Buitenlandse Handel en Ontwikkelingssamenwerking (2012-2021)
Commissie: algemene commissie voor Buitenlandse Handel en Ontwikkelingssamenwerking (2012-2021)
Bijlage
Deelnemers
-
R.P. van Laar (PvdA)
-
I.S.H. de Caluwé (VVD)
-
A.H. (Agnes) Mulder (CDA)
-
E.M.A. Smaling (SP)
Agendapunten
1
Gesprek met PDP-organisaties over het Product Development Partnership Fonds (PDP-fonds)
Naast KNCV Tuberculosefonds, AERAS en IAVI zal ook één vertegenwoordiger van de overige PDP's aan het gesprek deelnemen.
Het gaat om de volgende PDP's:
- Drugs for Neglected Diseases Initiative (DNDI)
- International Partnership for Microbicides
- Sabin
- Foundation for Innovative New Diagnostics (FIND)
- PATH/Protection Options for Women
PROGRAMME
Epidemiological update on poverty-related and neglected diseases (PRND): the importance of developing new health tools for those who need it most
The importance of product development partnerships in the fight against PRND
The value of collaboration with PDPs for Dutch partners from industry & academia
Leveraging the power of PPPs to save lives and improve health
Partnerships delivering products against PRND
Het gaat om de volgende PDP's:
- Drugs for Neglected Diseases Initiative (DNDI)
- International Partnership for Microbicides
- Sabin
- Foundation for Innovative New Diagnostics (FIND)
- PATH/Protection Options for Women
PROGRAMME
Epidemiological update on poverty-related and neglected diseases (PRND): the importance of developing new health tools for those who need it most
- Prof. Dr. Frank Cobelens, Scientific Director of KNCV Tuberculosis Foundation and Professor of Epidemiology and Control of Poverty-related Infectious Diseases at the Amsterdam Institute for Global Health and Development and the Amsterdam Medical Center
The importance of product development partnerships in the fight against PRND
- Dr. Lewis Schrager, VP of Scientific Affairs, Aeras
- Hester Kuipers, Executive Director IAVI Europe
The value of collaboration with PDPs for Dutch partners from industry & academia
- Prof. Dr. Hanneke Schuitemaker, Head Viral Vaccine Discovery and Translational Medicine, Crucell / Johnson & Johnson
- Prof. Dr. Peter Peters, Head of institute of Nanoscopy, Maastricht University
Leveraging the power of PPPs to save lives and improve health
- Dr. Mercy Ahun, Special representative to GAVI eligible countries
Partnerships delivering products against PRND
- Dr. Tim Wells, Chief Scientific Officer of Medicines for Malaria Venture (MVV)